• No results found

Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment

N/A
N/A
Protected

Academic year: 2022

Share "Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment"

Copied!
15
0
0

Laster.... (Se fulltekst nå)

Fulltekst

Referanser

RELATERTE DOKUMENTER

The intracranial administration of activated natural killer (NK) cells promotes cellular-dependent cytotoxicity against glioblastoma (GBM) (A) The NK cell-GBM cell interaction leads

High dose chemotherapy with autologous stem cell transplantation (HDT-ASCT).. Stem cell

It is essential to obtain a cell suspension free from undigested tissue and cell clumps, to effectively separate stromal stem cells from other cell types using

The methods describe (1) the preparation of cells to be reprogrammed (the “donor” cells), (2) the preparation of nuclear and cytoplasmic extracts, (3) the permeabilization of

Obstructive and restrictive pulmonary dysfunction in long-term lymphoma survivors after high-dose therapy with autologous stem cell transplantation.. Jo S

Our target group was people with some prior knowledge about stem cell knowledge and who wants to learn more about what influences stem cell research in different

Autologous hematopoietic stem cell transplantation as a treatment option for aggressive multiple sclerosis. Curr Treat

Methods Using patient-derived glioblastoma stem cell (GSC) cultures from 15 GBM patients, we described stem cell proper- ties of individual cultures, determined the